Key result
Ganglionated plexus ablation plus PVI is linked to ~58% lower PAF recurrence versus PVI alone.
Why the study?
Long-term outcomes of suppressing paroxysmal atrial fibrillation with additive ganglionated plexus ablation remain unknown.
Does ganglionated plexus ablation added to pulmonary vein isolation improve paroxysmal atrial fibrillation suppression in patients with paroxysmal atrial fibrillation?
Cohort (n=225)
Does ganglionated plexus ablation added to pulmonary vein isolation improve paroxysmal atrial fibrillation suppression in patients with paroxysmal atrial fibrillation?
Adding ganglionated plexus ablation to pulmonary vein isolation significantly improves long-term suppression of paroxysmal atrial fibrillation over 4 years compared to PVI alone.
Answers are grounded in this paper and cite their sources.
GPA plus PVI was associated with improved PAF suppression; leaves open need for randomized confirmation before practice change.
BackgroundLong-term outcomes of suppressing paroxysmal atrial fibrillation (PAF) with additive ganglionated plexus (GP) ablation (GPA) remains unknown.ObjectivesThe aim of the study is to assess potential role of additional GPA for PAF suppression.MethodsThis study consisted of 225 patients; 68 (group A: 58 male, aged 60 ± 11 years) underwent pulmonary vein isolation (PVI) alone and 157 (group B: 137 male, aged 61 ± 11 years) GPA followed by PVI. GPA was performed based on the high-density mapping with high-frequency stimulation (HFS) delivered to left atrial (LA) major GP. The latter 85 group B patients (54%) underwent ablation to a posteromedial area within superior vena cava as a part of dorsal right atrial GP (SVC-Ao GP).ResultsIn group B, HFS was applied to 126 ± 32 sites, with a median of 47 GP sites (40.0%) being ablated. In patients undergoing an SVC-Ao GPA, HFS and the SVC-Ao GPA were applied at a median of 15 and 4 sites (29.4%), respectively. The PVI with a GPA provided higher PAF suppression than a PVI alone during more than 4 years of follow-up (56.7% vs 38.2%, odds ratio: 0.42, 95% confidence interval: 0.23–0.76, P < .05), but the SVC-Ao GPA did not provide further suppressive effects. Multivariate analyses revealed that tachycardia-bradycardia syndrome and non-PV foci were independent predictors of PAF recurrence after PVI with a GPA (P < .01).ConclusionGPA to LA major GP by high-density mapping provides long-term benefits for PAF suppression over 4 years of follow-up, but the effect of an empiric SVC-Ao GPA could not be appreciated, suggesting little effect on suppressing non-PV foci. Long-term outcomes of suppressing paroxysmal atrial fibrillation (PAF) with additive ganglionated plexus (GP) ablation (GPA) remains unknown. The aim of the study is to assess potential role of additional GPA for PAF suppression. This study consisted of 225 patients; 68 (group A: 58 male, aged 60 ± 11 years) underwent pulmonary vein isolation (PVI) alone and 157 (group B: 137 male, aged 61 ± 11 years) GPA followed by PVI. GPA was performed based on the high-density mapping with high-frequency stimulation (HFS) delivered to left atrial (LA) major GP. The latter 85 group B patients (54%) underwent ablation to a posteromedial area within superior vena cava as a part of dorsal right atrial GP (SVC-Ao GP). In group B, HFS was applied to 126 ± 32 sites, with a median of 47 GP sites (40.0%) being ablated. In patients undergoing an SVC-Ao GPA, HFS and the SVC-Ao GPA were applied at a median of 15 and 4 sites (29.4%), respectively. The PVI with a GPA provided higher PAF suppression than a PVI alone during more than 4 years of follow-up (56.7% vs 38.2%, odds ratio: 0.42, 95% confidence interval: 0.23–0.76, P < .05), but the SVC-Ao GPA did not provide further suppressive effects. Multivariate analyses revealed that tachycardia-bradycardia syndrome and non-PV foci were independent predictors of PAF recurrence after PVI with a GPA (P < .01). GPA to LA major GP by high-density mapping provides long-term benefits for PAF suppression over 4 years of follow-up, but the effect of an empiric SVC-Ao GPA could not be appreciated, suggesting little effect on suppressing non-PV foci.
No takes yet. Share an insight, caveat, or question.
Morita et al. (2021) conducted a cohort in Paroxysmal atrial fibrillation (n=225). Ganglionated plexus ablation (GPA) followed by pulmonary vein isolation (PVI) vs. Pulmonary vein isolation (PVI) alone was evaluated on PAF suppression (OR 0.42, 95% CI 0.23-0.76, p=<.05). Ganglionated plexus ablation plus pulmonary vein isolation improved paroxysmal atrial fibrillation suppression compared to PVI alone over 4 years.
Synapse has enriched 10 related papers. Consider them for comparative context: